Approval · Notice of Compliance 3344 · 1997
APO-CEFACLOR: Notice of Compliance 3344
Issued January 17, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3344
- Date
- January 17, 1997
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-CEFACLOR | 02230263 | Cancelled Post Market |
| APO-CEFACLOR | 02230264 | Cancelled Post Market |